Atlas Trials

Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC

Clinical trial NCT06041477 · RECRUITING

Trial details

NCT number
NCT06041477
Sponsor
Sun Yat-sen University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatocellular CarcinomaChemotherapy EffectChemotherapeutic Toxicity
Start date
2023-10-31
Primary completion
2027-07-01
Enrollment
540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.